CoChat

Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.

Marek, G J, Seiden, L S · 1988 · The Journal of Pharmacology and Experimental Therapeutics
Cited by 43

The DOI matches its Crossref record.

Abstract

The effects of antidepressant drugs, administered with and without a 5-hydroxytryptamine (5-HT) antagonist that is not selective for 5-HT receptor subtypes, were assessed in rats responding under a differential-reinforcement-of-low-rate 72-second (DRL 72-s) schedule of reinforcement. The increases in reinforcement rate seen after low dose tricyclic antidepressant drug administration were antagonized by the 5-HT antagonist methysergide. Methysergide did not antagonize either the increases in reinforcement rate or the decreases in response rate induced by the atypical antidepressant trazodone or the putative antidepressant clenbuterol. In addition, the effects of 5-HT receptor antagonists with varying selectivity for the 5-HT2 relative to the 5-HT1 receptor subtypes were assessed when administered alone. The rank order potency series for the maximal increase in the reinforcement rate after administration of the 5-HT antagonists was ketanserin greater than pipamperone greater than trazodone greater than cyproheptadine greater than cinanserin greater than metergoline greater than methysergide, in close agreement with the selectivity of these drugs for the 5-HT2 relative to the 5-HT1 receptor subtypes. In addition, the specificity of the DRL 72-s schedule was further assessed with the alpha adrenergic antagonists phentolamine and phenoxybenzamine which both decreased the response rate but did not increase the reinforcement rate as do antidepressant drugs. These results suggest that the therapeutic effect of atypical antidepressants such as trazodone and mianserin may be related to selective antagonism of 5-HT2 receptors. Furthermore, agonist action at a 5-HT1 receptor and antagonist action at 5-HT2 receptors both appear to contribute to antidepressant-like activity on the DRL 72-s schedule.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-3565(25)24458-5

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 43

Metadata

Authors
Marek, G. J., & Seiden, L. S.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
1988-02
Volume
244
Issue
2
Pages
650-658
ISSN
0022-3565 (ISSN-L)
OpenAlex
W1959120323
Cited by
43
References
0
FWCI
0.92
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule. https://app.cochat.ai/papers/10.1016/s0022-3565(25)24458-5
The paper
Marek, G. J., & Seiden, L. S. (1988). Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(25)24458-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.